UPDATE : Wednesday, August 5, 2020
상단여백
Heathcare experts shun online meetings: survey by Kim Yun-mi 2020-05-29 16:55
Kisqali offers survival benefit to breast cancer patients with visceral metastases by Kim Yun-mi 2020-05-29 10:58
Kolmar Korea sells off its pharma business to IMM Private Equity by Lee Han-soo 2020-05-28 12:11
[News Focus] Remdesivir alone not enough to kill Covid-19 by Kim Yun-mi 2020-05-27 14:20
JW Pharm to suffer most from suspended sale of 31 diabetes drugs by Park Gi-taek 2020-05-27 11:26
라인
MSD-Eisai combo therapy wins nod as indication for endometrial cancer by Shim Hyun-tai 2020-05-26 17:30
‘GSK's Synflorix prevents ear infection more effectively than PCV13’ by Shim Hyun-tai 2020-05-26 17:26
Daewoong partners with Inventage Lab for long-acting drug by Shim Hyun-tai 2020-05-25 18:25
GSK’s HIV treatment to get insurance benefits by Lee Han-soo 2020-05-25 14:55
Meditoxin’s future uncertain, even as final verdict nears by Jeong Sae-im 2020-05-25 14:38
라인
Fall in new Covid-19 cases hampers developing treatment by Jeong Sae-im 2020-05-22 17:31
Korean pharma’s Q1 performance not affected by Covid-19 by Kim Yun-mi 2020-05-22 17:29
Chinese regulator OKs Genexine's P2 trial of glioblastoma treatment by Lee Han-soo 2020-05-22 17:23
JW Pharma launches long-lasting hydraulic acid filler by Lee Han-soo 2020-05-22 16:20
‘No reckless interpretations of Moderna’s Covid-19 vaccine results’   by Kim Yun-mi 2020-05-22 15:27
라인
Alvogen’s obesity drug threatens Novo Nordisk's stronghold in Korea by Lee Han-soo 2020-05-22 15:19
Alvogen Korea to market Luye Pharma’s schizophrenia treatment by Lee Han-soo 2020-05-21 17:02
[Exclusive] Thailand recalls Medytox’s botulinum toxin by Jeong Sae-im 2020-05-21 12:33
SK’s offshoot picked as major raw material supplier to US by Shim Hyun-tai 2020-05-20 18:32
Eisai Korea expands indication for epilepsy treatment by Lee Han-soo 2020-05-20 17:11
여백
여백
여백
Back to Top